The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach

F Blasi, E Concia, B Del Prato, M Giusti… - Journal of …, 2017 - Taylor & Francis
Lower respiratory tract infections (LRTIs) cause high morbidity and mortality worldwide.
Empiric therapy often base the choice of antibiotic treatment on antibacterial spectrum of the …

[PDF][PDF] The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation …

F Di Marco, F Braido, P Santus… - Eur Rev Med …, 2014 - academia.edu
OBJECTIVES: Lower respiratory tract infections (LRTIs), including pneumonia and acute
exacerbations of Chronic Obstructive Pulmonary Disease (COPD), are among the most …

The management of acute lower respiratory tract infection in adults in primary care

M Thomas - Primary Care Respiratory Journal, 2000 - nature.com
Lower respiratory tract infection (LRTI) is common, usually causing self-limiting episodes of
ill health, but occasionally resulting in serious illness and mortality—particularly in the …

Cefpodoxime in the outpatient treatment of lower respiratory tract infections

J Minov, S Stoleski, T Petrova… - Academic Medical …, 2021 - repository.ukim.mk
Introduction. According to the recent data, lower respiratory tract infections (LRTIs), ie a
broad terminology including acute bronchitis (AB), influenza, community-acquired …

A randomised, multicentre study of ceftriaxone versus standard therapy in the treatment of lower respiratory tract infections

GJ De Klerk, JHM Van Steijn, S Lobatto… - International journal of …, 1999 - Elsevier
In this study the efficacy and cost-effectiveness of iv ceftriaxone 1 g once daily (CTX) was
compared with standard iv antibiotic treatment (STD) for lower respiratory tract infections …

[HTML][HTML] Decalogue for the selection of oral antibiotics for lower respiratory tract infections

R Cantón, J Barberán, M Linares… - Revista Española de …, 2022 - ncbi.nlm.nih.gov
Lower respiratory tract infections, including chronic obstructive pulmonary disease
exacerbations (COPD-E) and community acquired pneumonia (CAP), are one of the most …

An update on the pharmacotherapeutic management of lower respiratory tract infections

M Cazzola, P Rogliani, S Aliberti, F Blasi… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Our knowledge about lower respiratory tract infections (LRTIs) has improved
substantially in the last years, but the management of respiratory infections is still a …

A guide to the treatment of lower respiratory tract infections

F Vogel - Drugs, 1995 - Springer
Acute bronchitis is usually a viral infection which, unless there is a special disposition, does
not require antibiotic therapy. For the initial oral chemotherapy of bacterial infections of the …

New antibiotics for community-acquired lower respiratory tract infections: improved activity at a cost?

P Ball - International journal of antimicrobial agents, 2000 - Elsevier
Opinions are changing as to the continued validity of traditional beta-lactam and macrolide
therapy of community acquired LRTI, partly because of resistance and partly because of …

[HTML][HTML] Systematic literature review of real-world evidence of ceftolozane/tazobactam for the treatment of respiratory infections

L Puzniak, R Dillon, T Palmer, H Collings… - Infectious Diseases and …, 2021 - Springer
Introduction Gram-negative nosocomial pneumonia (NP), including hospital-acquired
bacterial pneumonia (HABP), ventilated HABP (vHABP), and ventilator-associated bacterial …